Pedro Castillo-Valdez

Mr. Pedro Castillo-Valdez

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2023 in Education Sciences
Verified
Journal Article
Open access
PDF file
Marisela Rodríguez-SalvadorMarisela Rodríguez-Salvador
Marisela Rodríguez-Salvador
PCPedro Castillo-Valdez
Pedro Castillo-Valdez
For students to compete in the globalized world, it is essential to be proficient not only in knowledge but also in soft skills. Students should know how to work collaboratively towards a common goal; in this sense, it is recommended for educators to enhance collaborative learning competency, particularly in students in the final part of their studies. Important efforts have been made to study collaborative learning; however, those that focus on collaborative competencies in engineering students close to finishing their studies have not yet been explored. In this context, this research proposes a teaching–learning model named “Colabora” to foster collaborative competencies in students soon to graduate from an industrial engineering program. It includes the development of a progressive final project, the use of a digital platform, and specific assessment tools. An exploratory study was conducted in a private university in Mexico during a semester-long innovation management course. Results show that the students who applied “Colabora” obtained the most knowledge on the subject of innovation management and showed greater collaborative competence. This approach adds value for educators and researchers interested in fostering collaborative competencies useful for future professionals that work in teams pursuing common goals.

31 March 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SPSamir I. Paipa-Jabre-Cantu
Samir I. Paipa-Jabre-Cantu
Marisela Rodríguez-SalvadorMarisela Rodríguez-Salvador
Marisela Rodríguez-Salvador
PCPedro Castillo-Valdez
Pedro Castillo-Valdez
Background/Objectives. Central nervous system (CNS)-related diseases such as Alzheimer’s and Parkinson’s, Attention Deficit Hyperactive Disorder (ADHD), stroke, epilepsy, and migraines are leading causes of morbidity and disability worldwide. New solutions for drug delivery are increasingly needed. In this context, three-dimensional (3D) printing technology has introduced innovative alternatives to produce more efficient medicines with diverse features, patterns, and consistencies, particularly oral medications. Even though research in this area is growing rapidly, no study has thoroughly analyzed 3D printing oral drug delivery progress for the CNS. To fill this gap this study pursues to determine a technological landscape in this field. Methods. For this aim, a Competitive Technology Intelligence (CTI) methodology was applied, examining 747 publications from 1 January 2019 to 20 May 2024 published in the Scopus database. Results. The main advances identified comprise six categories: 3D printing techniques, characteristics and applications, materials, design factors, user acceptance, and quality processes. FDM was identified as the main technique for pharmaceutical use. The main applications include pills, polypills, caplets, gel caps, multitablets, orodispersible films, and tablets, featuring external patterns and internal structures with one or more active substances. Insights show that the most utilized materials are thermoplastic polymers like PLA, PVA, PCL, ABS, and HIPS. A novel design factor involves release patterns using compartments of varying thicknesses and volumes in the core. Additionally, advances in specialized software have enabled the creation of highly complex designs. In the user acceptance category, oral drugs dosages are tailored to the specific needs and preferences of neurological patients. Finally, for the quality aspect, the precision in Active Pharmaceutical Ingredient (API) dosage and controlled-release mechanisms are critical, given the narrow margin between therapeutic doses and toxicity for CNS diseases. Conclusions. Revealing these advancements in 3D printing for oral drug delivery allows researchers, academics, and decision-makers to identify opportunities and allocate resources efficiently, promising enhanced oral medicaments for the health and well-being of individuals suffering from CNS disorders.

27 March 2023 in Foresight-Russia
Verified
Journal Article
Open access
FPFrancisco Paredes-Leon
Francisco Paredes-Leon
Marisela Rodríguez-SalvadorMarisela Rodríguez-Salvador
Marisela Rodríguez-Salvador
PCPedro Castillo-Valdez
Pedro Castillo-Valdez
This paper examines the benefits of and barriers to technology transfers from academia to industry perceived by entrepreneurs and particularly associated with the dimensions of Entrepreneurial Capacity. This study is one of the first in which the analysis of the topic goes beyond the high-tech sectors. It is based on a survey of representatives of Small and Medium Enterprises (SMEs) dedicated to the production of Leather and Footwear in Peru. The main findings were that the Absorption Capability dimension had a positive relationship coefficient with the understanding of the benefits of and barriers to technology transfers, while the Networking Diversity dimension presented a negative relationship coefficient. Likewise, this study shows that the main barriers to technology transfer were the fear of information leaks and the lack of training. The results of this research can add value to decision makers in industry, academia, and government agencies interested in science and technology policies.

22 August 2024 in JMIR Diabetes
Verified
Journal Article
Open access
PCPedro Castillo-Valdez
Pedro Castillo-Valdez
Marisela Rodríguez-SalvadorMarisela Rodríguez-Salvador
Marisela Rodríguez-Salvador
Yuh-Shan HoYuh-Shan Ho
Yuh-Shan Ho
Background: The widespread use of mobile technologies in health care (mobile health; mHealth) has facilitated disease management, especially for chronic illnesses such as diabetes. mHealth for diabetes is an attractive alternative to reduce costs and overcome geographical and temporal barriers to improve patients’ conditions. Objective: This study aims to reveal the dynamics of scientific publications on mHealth for diabetes to gain insights into who are the most prominent authors, countries, institutions, and journals and what are the most cited documents and current hot spots. Methods: A scientometric analysis based on a competitive technology intelligence methodology was conducted. An innovative 8-step methodology supported by experts was executed considering scientific documents published between 1998 and 2021 in the Science Citation Index Expanded database. Publication language, publication output characteristics, journals, countries and institutions, authors, and most cited and most impactful articles were identified. Results: The insights obtained show that a total of 1574 scientific articles were published by 7922 authors from 90 countries, with an average of 15 (SD 38) citations and 6.5 (SD 4.4) authors per article. These documents were published in 491 journals and 92 Web of Science categories. The most productive country was the United States, followed by the United Kingdom, China, Australia, and South Korea, and the top 3 most productive institutions came from the United States, whereas the top 3 most cited articles were published in 2016, 2009, and 2017 and the top 3 most impactful articles were published in 2016 and 2017. Conclusions: This approach provides a comprehensive knowledge panorama of research productivity in mHealth for diabetes, identifying new insights and opportunities for research and development and innovation, including collaboration with other entities, new areas of specialization, and human resource development. The findings obtained are useful for decision-making in policy planning, resource allocation, and identification of research opportunities, benefiting researchers, health professionals, and decision makers in their efforts to make significant contributions to the advancement of diabetes science.

11 April 2024 in Foresight-Russia
Verified
Journal Article
Open access
PCPedro Castillo-Valdez
Pedro Castillo-Valdez
Marisela Rodríguez-SalvadorMarisela Rodríguez-Salvador
Marisela Rodríguez-Salvador
YHYuh-Shan Ho
Yuh-Shan Ho
In recent years, more and more generic technologies have appeared, allowing one to find answers simultaneously along different dimensions, “fan” solutions for urgent and complex problems are synthesized and cumulative effects emerge. This article analyzes the potential of such technologies using the example of mobile health (mHealth), which provides rapid access to medical services even in the most remote regions, mitigating the inequalities between different segments of the population in this regard. The implementation of mobile health becomes especially important in the context of the rapid spread of chronic and autoimmune diseases, which strongly impact the quality and duration of life. Smart applications based on AI and virtual reality provide the opportunity to manage one’s health by combining patient self-monitoring with rapid consultations with medical staff. By doing so, risks are reduced and physiological and mental well-being is enhanced. This article conducts a large-scale literature review of diabetes management techniques through mobile technology to systematize and identify the most advanced solutions. For such innovations to maximize their impact, public health policies must be aligned with a digitalization strategy.

28 August 2023 in JMIR Preprints
Verified
Preprint
Open access
PCPedro Castillo-Valdez
Pedro Castillo-Valdez
Marisela Rodríguez-SalvadorMarisela Rodríguez-Salvador
Marisela Rodríguez-Salvador
Yuh-Shan HoYuh-Shan Ho
Yuh-Shan Ho
BACKGROUND The widespread use of mobile technologies in health care (mobile health; mHealth) has facilitated disease management, especially for chronic illnesses such as diabetes. mHealth for diabetes is an attractive alternative to reduce costs and overcome geographical and temporal barriers to improve patients’ conditions. OBJECTIVE This study aims to reveal the dynamics of scientific publications on mHealth for diabetes to gain insights into who are the most prominent authors, countries, institutions, and journals and what are the most cited documents and current hot spots. METHODS A scientometric analysis based on a competitive technology intelligence methodology was conducted. An innovative 8-step methodology supported by experts was executed considering scientific documents published between 1998 and 2021 in the Science Citation Index Expanded database. Publication language, publication output characteristics, journals, countries and institutions, authors, and most cited and most impactful articles were identified. RESULTS The insights obtained show that a total of 1574 scientific articles were published by 7922 authors from 90 countries, with an average of 15 (SD 38) citations and 6.5 (SD 4.4) authors per article. These documents were published in 491 journals and 92 Web of Science categories. The most productive country was the United States, followed by the United Kingdom, China, Australia, and South Korea, and the top 3 most productive institutions came from the United States, whereas the top 3 most cited articles were published in 2016, 2009, and 2017 and the top 3 most impactful articles were published in 2016 and 2017. CONCLUSIONS This approach provides a comprehensive knowledge panorama of research productivity in mHealth for diabetes, identifying new insights and opportunities for research and development and innovation, including collaboration with other entities, new areas of specialization, and human resource development. The findings obtained are useful for decision-making in policy planning, resource allocation, and identification of research opportunities, benefiting researchers, health professionals, and decision makers in their efforts to make significant contributions to the advancement of diabetes science.